新的缺氧诱导的HIF-1α激活在喘病原发生过程中
Mengzhi Wan1, Qi Yu1, Fei Xu1
1Department of Respiratory Emergency and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Zheng Street, Nanchang, Jiangxi Province, 330006, PR China.
Respiratory research
|July 26, 2024
概括
缺氧诱导因子-1α (HIF-1α) 通过通过P53无处置增强气道光滑肌细胞功能,促进喘恶化. 针对HIF-1α-MDM2-P53通路提供了潜在的新喘治疗方法.
科学领域:
- 呼吸系统药物 呼吸系统药物
- 分子生物学分子生物学
- 细胞病理学 细胞病理学
背景情况:
- 喘涉及复杂的呼吸道炎症和重塑,因缺氧而加剧.
- 缺氧诱导因子-1α (HIF-1α) 和P53的无处不在与喘病因产生有关.
研究的目的:
- 研究HIF-1α-MDM2-P53轴在喘恶化中的作用.
- 探索喘的潜在治疗点.
主要方法:
- 利用高通量测序和生物信息学进行基因关联分析.
- 使用呼吸道光滑肌细胞 (ASMCs) 开发了体内喘小鼠模型和体内低氧模型.
- 评估细胞功能 (活力,增殖,迁移,亡),并进行ELISA和H&E染色.
主要成果:
- 在喘模型中,HIF-1α被显著上调.
- HIF-1α促进了ASMC的活力,增殖和迁移,同时抑制了通过MDM2-诱导的P53无处置介导的亡.
- 用IDF-11,774抑制这种途径可以减少呼吸道炎症和体内结构变化.
结论:
- 在喘恶化时,HIF-1α-MDM2-P53轴至关重要.
- 调节这种途径为喘治疗提供了一个有前途的治疗策略.
相关概念视频
Asthma: Pathogenesis and Management
379
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
379
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Acute Respiratory Failure-II
192
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
192


